ABVC BioPharma Inc (ABVC)
1.49
-0.10
(-6.29%)
USD |
NASDAQ |
Apr 26, 16:00
1.44
-0.05
(-3.36%)
After-Hours: 20:00
ABVC BioPharma Cash from Investing (Quarterly): 0.1542M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.1542M |
| September 30, 2023 | -0.0738M |
| June 30, 2023 | -0.4406M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0833M |
| September 30, 2022 | -1.523M |
| June 30, 2022 | -0.022M |
| March 31, 2022 | -0.0932M |
| December 31, 2021 | 0.4268M |
| September 30, 2021 | -0.8108M |
| June 30, 2021 | -0.14M |
| March 31, 2021 | -0.282M |
| December 31, 2020 | 0.1071M |
| September 30, 2020 | -0.3658M |
| June 30, 2020 | 0.0333M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0002M |
| September 30, 2019 | -0.0141M |
| June 30, 2019 | -0.0032M |
| March 31, 2019 | -0.0178M |
| December 31, 2018 | -0.3143M |
| September 30, 2018 | 0.2055M |
| June 30, 2018 | 0.1088M |
| March 31, 2018 | 0.00 |
| September 30, 2017 |
| Date | Value |
|---|---|
| June 30, 2017 | |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | -0.0019M |
| March 31, 2012 | 0.0004M |
| December 31, 2011 | -0.018M |
| September 30, 2011 | -0.001M |
| June 30, 2011 | -0.0158M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.523M
Minimum
Sep 2022
0.4268M
Maximum
Dec 2021
-0.1648M
Average
-0.022M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | 0.00 |
| Sutro Biopharma Inc | -23.51M |
| Reviva Pharmaceuticals Holdings Inc | -- |
| Flora Growth Corp | 0.038M |
| Journey Medical Corp | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.4795M |
| Cash from Financing (Quarterly) | 0.0874M |
| Free Cash Flow | -4.257M |
| Free Cash Flow Per Share (Quarterly) | -0.0606 |
| Free Cash Flow to Equity (Quarterly) | 0.5583M |
| Free Cash Flow to Firm (Quarterly) | 0.6456M |
| Free Cash Flow Yield | -61.49% |